MGAT4B and melanoma: Further exploration into the genetic alterations affecting MGAT4B revealed that ~10% of melanoma patients harbor amplifications in MGAT4B, which could explain aberrantly high levels of MGAT4B expression in affected individuals (SI Appendix, Fig. S8B).